68 related articles for article (PubMed ID: 8052873)
1. Small cell lung cancer in the elderly.
Byrne A; Carney DN
Semin Oncol; 1994 Jun; 21(3 Suppl 6):43-8. PubMed ID: 8052873
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
4. Overview of chemotherapy for small cell lung cancer.
Bunn PA; Carney DN
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-69-S7-74. PubMed ID: 9194484
[TBL] [Abstract][Full Text] [Related]
5. [Recent topics in chemotherapy for elderly patients with lung cancer].
Okamoto H; Watanabe K
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1097-104. PubMed ID: 10945002
[TBL] [Abstract][Full Text] [Related]
6. Combined modality therapy of lung cancer.
Livingston RB
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
[TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer].
Tada A; Ueoka H; Kiura K; Tabata M; Takemoto M; Yamane H; Hiyama J; Aoe K; Shibayama T; Kamei H; Kawahara S; Harita S; Sato T; Kobayashi M; Eguchi K; Hiraki S; Hiraki Y; Tanimoto M
Gan To Kagaku Ryoho; 2002 May; 29(5):751-6. PubMed ID: 12040679
[TBL] [Abstract][Full Text] [Related]
8. Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly.
Schild SE; Stella PJ; Brooks BJ; Mandrekar S; Bonner JA; McGinnis WL; Mailliard JA; Krook JE; Deming RL; Adjei AA; Jatoi A; Jett JR
Cancer; 2005 Jun; 103(11):2349-54. PubMed ID: 15852407
[TBL] [Abstract][Full Text] [Related]
9. The role of ifosfamide in small cell lung cancer.
Loehrer PJ
Semin Oncol; 1996 Jun; 23(3 Suppl 7):40-4. PubMed ID: 8711501
[TBL] [Abstract][Full Text] [Related]
10. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
Leyvraz S; Pampallona S; Martinelli G; Ploner F; Perey L; Aversa S; Peters S; Brunsvig P; Montes A; Lange A; Yilmaz U; Rosti G;
J Natl Cancer Inst; 2008 Apr; 100(8):533-41. PubMed ID: 18398095
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
12. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
Bunn PA
Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
[TBL] [Abstract][Full Text] [Related]
13. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E
Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy for small cell lung cancer.
Sufarlan AW; Zainudin BM
Med J Malaysia; 1993 Jun; 48(2):166-70. PubMed ID: 8394502
[TBL] [Abstract][Full Text] [Related]
15. Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience.
Yamamoto N; Tamura T; Fukuoka M; Saijo N
Int J Oncol; 1999 Oct; 15(4):737-41. PubMed ID: 10493956
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
[TBL] [Abstract][Full Text] [Related]
17. A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
Sculier JP; Paesmans M; Lecomte J; Van Cutsem O; Lafitte JJ; Berghmans T; Koumakis G; Florin MC; Thiriaux J; Michel J; Giner V; Berchier MC; Mommen P; Ninane V; Klastersky J;
Br J Cancer; 2001 Nov; 85(10):1444-51. PubMed ID: 11720426
[TBL] [Abstract][Full Text] [Related]
18. [Pilot study of dose intensive weekly chemotherapy followed by cisplatin plus etoposide with concurrent thoracic irradiation for limited-disease small-cell lung cancer. West Japan Thoracic Oncology Group].
Isobe T; Fukuoka M; Negoro S; Sugiura T; Kawahara M; Kudoh S; Araki J; Nakagawa K; Yokozaki M; Yamakido M; Ariyoshi Y
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1091-6. PubMed ID: 10945001
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
[TBL] [Abstract][Full Text] [Related]
20. [Is there progress in the chemotherapy of small cell lung cancer?].
Calderoni A; Cerny T; Betticher DC
Schweiz Med Wochenschr; 1999 Sep; 129(37):1313-20. PubMed ID: 10515004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
